Rosenbaum Jennifer, Lucas Nicole, Zandrow Gregory, Satz Wayne A, Isenberg Derek, D'Orazio Joseph, Gentile Nina T, Schreyer Kraftin E
Department of Emergency Medicine, Temple University Hospital, 1316 W. Ontario Street, 10(th) Floor Jones Hall, Philadelphia, PA 19140, United States.
Am J Emerg Med. 2021 Mar;41:51-54. doi: 10.1016/j.ajem.2020.12.047. Epub 2020 Dec 30.
Since the beginning of the novel coronavirus (COVID-19) pandemic in the United States, there have been concerns about the potential impact of the pandemic on persons with opioid use disorder. Shelter-in-place (SIP) orders, which aimed to reduce the spread and scope of the virus, likely also impacted this patient population. This study aims to assess the role of the COVID-19 pandemic on the incidence of opioid overdose before and after a SIP order.
A retrospective review of the incidence of opioid overdoses in an urban three-hospital system was conducted. Comparisons were made between the first 100 days of a city-wide SIP order during the COVID-19 pandemic and the 100 days during the COVID-19 pandemic preceding the SIP order (Pre-SIP). Differences in observed incidence and expected incidence during the SIP period were evaluated using a Fisher's Exact test.
Total patient visits decreased 22% from 46,078 during the Pre-SIP period to 35,971 during the SIP period. A total of 1551 opioid overdoses were evaluated during the SIP period, compared to 1665 opioid overdoses during the Pre-SIP period, consistent with a 6.8% decline. A Fisher's Exact Test demonstrated a p < 0.0001, with a corresponding Odds Ratio of 1.20 with a 95% confidence interval (1.12;1.29).
The COVID-19 pandemic and the associated SIP order were associated with a statistically and clinically significant increase in the proportion of opioid overdoses in relation to the overall change in total ED visits.
自美国新型冠状病毒(COVID-19)大流行开始以来,人们一直担心该大流行对患有阿片类药物使用障碍的人群的潜在影响。旨在减少病毒传播和范围的就地避难(SIP)命令可能也对这一患者群体产生了影响。本研究旨在评估COVID-19大流行在SIP命令前后对阿片类药物过量发生率的作用。
对一个城市三医院系统中阿片类药物过量的发生率进行回顾性研究。对COVID-19大流行期间全市SIP命令的前100天与SIP命令之前(SIP前)的COVID-19大流行期间的100天进行了比较。使用Fisher精确检验评估SIP期间观察到的发病率与预期发病率的差异。
患者就诊总数从SIP前期间的46,078人次下降了22%,至SIP期间的35,971人次。在SIP期间共评估了1551例阿片类药物过量,而在SIP前期间为1665例阿片类药物过量,下降了6.8%。Fisher精确检验显示p<0.0001,相应的优势比为1.20,95%置信区间为(1.12;1.29)。
COVID-19大流行及相关的SIP命令与急诊就诊总数总体变化相关的阿片类药物过量比例在统计学和临床上的显著增加有关。